Teva Womens Drug Patent Portfolio
Teva Womens owns 8 orange book drugs protected by 4 US patents with Adderall 10 having the least patent protection, holding only 2 patents. And Prefest with maximum patent protection, holding 2 patents. Given below is the list of Teva Womens's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US6384020 | Rapid immediate release oral dosage form | 06 Jan, 2021 | Expired | 
| US6384020 | Rapid immediate release oral dosage form | 06 Jul, 2020 | Expired | 
| US7320970 | Low dose estrogen interrupted hormone replacement therapy | 30 Mar, 2020 | Expired | 
| US6747019 | Low dose estrogen interrupted hormone replacement therapy | 20 Mar, 2020 | Expired | 
Latest Legal Activities on Teva Womens's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Teva Womens.
| Activity | Date | Patent Number | 
|---|---|---|
|   | ||
| Expire Patent  Critical
                   | 24 Feb, 2020 | US7320970 | 
| Maintenance Fee Reminder Mailed  Critical
                   | 09 Sep, 2019 | US7320970 | 
| Patent Issue Date Used in PTA Calculation  Critical
                   | 22 Jan, 2008 | US7320970 | 
| Recordation of Patent Grant Mailed  Critical
                   | 22 Jan, 2008 | US7320970 | 
| Issue Notification Mailed  Critical
                   | 02 Jan, 2008 | US7320970 | 
| Dispatch to FDC | 18 Dec, 2007 | US7320970 | 
| Application Is Considered Ready for Issue  Critical
                   | 06 Dec, 2007 | US7320970 | 
| Issue Fee Payment Verified  Critical
                   | 27 Nov, 2007 | US7320970 | 
| Issue Fee Payment Received  Critical
                   | 27 Nov, 2007 | US7320970 | 
| Mail Notice of Allowance  Critical
                   | 27 Aug, 2007 | US7320970 | 
| Notice of Allowance Data Verification Completed  Critical
                   | 23 Aug, 2007 | US7320970 | 
| PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED  Critical
                   | 14 Aug, 2007 | US7320970 | 
| Date Forwarded to Examiner | 06 Aug, 2007 | US7320970 | 
| Terminal Disclaimer Filed  Critical
                   | 02 Aug, 2007 | US7320970 | 
| Request for Extension of Time - Granted  Critical
                   | 02 Aug, 2007 | US7320970 | 
Teva Womens's Family Patents
 
 Teva Womens Drug List
Given below is the complete list of Teva Womens's drugs and the patents protecting them.
1. Adderall 10
Adderall 10 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US6384020 
                  (Pediatric)
                 | Rapid immediate release oral dosage form | 06 Jan, 2021 
                  (4 years ago)
                 | Expired | 
| US6384020 | Rapid immediate release oral dosage form | 06 Jul, 2020 
                  (5 years ago)
                 | Expired | 
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 10's drug page
2. Adderall 12.5
Adderall 12.5 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US6384020 
                  (Pediatric)
                 | Rapid immediate release oral dosage form | 06 Jan, 2021 
                  (4 years ago)
                 | Expired | 
| US6384020 | Rapid immediate release oral dosage form | 06 Jul, 2020 
                  (5 years ago)
                 | Expired | 
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 12.5's drug page
3. Adderall 15
Adderall 15 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US6384020 
                  (Pediatric)
                 | Rapid immediate release oral dosage form | 06 Jan, 2021 
                  (4 years ago)
                 | Expired | 
| US6384020 | Rapid immediate release oral dosage form | 06 Jul, 2020 
                  (5 years ago)
                 | Expired | 
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 15's drug page
4. Adderall 20
Adderall 20 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US6384020 
                  (Pediatric)
                 | Rapid immediate release oral dosage form | 06 Jan, 2021 
                  (4 years ago)
                 | Expired | 
| US6384020 | Rapid immediate release oral dosage form | 06 Jul, 2020 
                  (5 years ago)
                 | Expired | 
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 20's drug page
5. Adderall 30
Adderall 30 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US6384020 
                  (Pediatric)
                 | Rapid immediate release oral dosage form | 06 Jan, 2021 
                  (4 years ago)
                 | Expired | 
| US6384020 | Rapid immediate release oral dosage form | 06 Jul, 2020 
                  (5 years ago)
                 | Expired | 
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 30's drug page
Explore Our Curated Drug Screens
6. Adderall 5
Adderall 5 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US6384020 
                  (Pediatric)
                 | Rapid immediate release oral dosage form | 06 Jan, 2021 
                  (4 years ago)
                 | Expired | 
| US6384020 | Rapid immediate release oral dosage form | 06 Jul, 2020 
                  (5 years ago)
                 | Expired | 
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 5's drug page
7. Adderall 7.5
Adderall 7.5 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US6384020 
                  (Pediatric)
                 | Rapid immediate release oral dosage form | 06 Jan, 2021 
                  (4 years ago)
                 | Expired | 
| US6384020 | Rapid immediate release oral dosage form | 06 Jul, 2020 
                  (5 years ago)
                 | Expired | 
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 7.5's drug page
8. Prefest
Prefest is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US7320970 | Low dose estrogen interrupted hormone replacement therapy | 30 Mar, 2020 
                  (5 years ago)
                 | Expired | 
| US6747019 | Low dose estrogen interrupted hormone replacement therapy | 20 Mar, 2020 
                  (5 years ago)
                 | Expired | 
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prefest's drug page
